MedPath

UNIVERSITY OF ARIZONA

UNIVERSITY OF ARIZONA logo
🇺🇸United States
Ownership
Private
Established
1885-01-01
Employees
10K
Market Cap
-
Website
http://www.arizona.edu

Green Tea Extract (Polyphenon E) in Preventing Cancer in Healthy Participants

Phase 1
Completed
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
First Posted Date
2004-09-09
Last Posted Date
2010-01-20
Lead Sponsor
University of Arizona
Registration Number
NCT00091325
Locations
🇺🇸

Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson, Arizona, United States

Amifostine Plus Topotecan in Treating Patients With Myelodysplastic Syndrome

Phase 1
Completed
Conditions
Leukemia
Myelodysplastic Syndromes
First Posted Date
2004-08-03
Last Posted Date
2013-01-31
Lead Sponsor
University of Arizona
Target Recruit Count
26
Registration Number
NCT00003415
Locations
🇺🇸

Arizona Cancer Center, Tucson, Arizona, United States

High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
Drug/Agent Toxicity by Tissue/Organ
First Posted Date
2004-08-02
Last Posted Date
2013-01-31
Lead Sponsor
University of Arizona
Target Recruit Count
30
Registration Number
NCT00003068
Locations
🇺🇸

Arizona Cancer Center, Tucson, Arizona, United States

Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer

Phase 1
Completed
Conditions
Chronic Myeloproliferative Disorders
Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes
Precancerous/Nonmalignant Condition
Unspecified Adult Solid Tumor, Protocol Specific
First Posted Date
2004-07-19
Last Posted Date
2010-03-16
Lead Sponsor
University of Arizona
Target Recruit Count
27
Registration Number
NCT00003082
Locations
🇺🇸

Arizona Cancer Center, Tucson, Arizona, United States

Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer

Phase 2
Completed
Conditions
Prostate Cancer
Radiation Toxicity
First Posted Date
2004-04-14
Last Posted Date
2010-03-16
Lead Sponsor
University of Arizona
Target Recruit Count
25
Registration Number
NCT00003307
Locations
🇺🇸

Arizona Cancer Center, Tucson, Arizona, United States

Selenium for Prevention of Adenomatous Colorectal Polyps

Phase 3
Terminated
Conditions
Precancerous Condition
Colorectal Cancer
Adenomatous Colorectal Polyps
Interventions
First Posted Date
2004-03-09
Last Posted Date
2019-09-24
Lead Sponsor
University of Arizona
Target Recruit Count
1621
Registration Number
NCT00078897
Locations
🇺🇸

Endoscopy Center of Western New York, Williamsville, New York, United States

🇺🇸

Baylor University Medical Center - Dallas, Dallas, Texas, United States

🇺🇸

Veterans Affairs Medical Center - Phoenix, Phoenix, Arizona, United States

and more 4 locations

Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis

Phase 2
Completed
Conditions
Precancerous/Nonmalignant Condition
Non-melanomatous Skin Cancer
First Posted Date
2004-02-16
Last Posted Date
2018-09-11
Lead Sponsor
University of Arizona
Registration Number
NCT00021294
Locations
🇺🇸

Arizona Cancer Center, Tucson, Arizona, United States

Multidisciplinary Study of Right Ventricular Dysplasia

Completed
Conditions
Heart Diseases
Arrhythmogenic Right Ventricular Dysplasia
First Posted Date
2001-09-18
Last Posted Date
2013-01-17
Lead Sponsor
University of Arizona
Target Recruit Count
320
Registration Number
NCT00024505
Locations
🇺🇸

University of Arizona, Tucson, Arizona, United States

Bone Estrogen Strength Training

Phase 2
Completed
Conditions
Osteoporosis
First Posted Date
1999-11-04
Last Posted Date
2013-05-20
Lead Sponsor
University of Arizona
Target Recruit Count
300
Registration Number
NCT00000399
Locations
🇺🇸

Ina Gittings Bldg. Body Composition Laboratory, Tucson, Arizona, United States

© Copyright 2025. All Rights Reserved by MedPath